科兴生物 (sva.o)

+ 收藏

资产负债表(科兴生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
截止日期 2023-12-312023-06-302022-12-312022-06-30
报表类型 合并报表合并报表合并报表合并报表
报表年结日 1231123112311231
原始币种 美元美元美元美元
上市前/上市后 上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 1,270,131,000.001,643,026,000.004,278,124,000.006,857,905,000.00
 受限制存款及现金流动(元) 5,166,000.003,734,000.008,253,000.009,189,000.00
 应收账款及票据(元) 440,019,000.00425,245,000.00537,118,000.00969,561,000.00
 预付款项及其他应收款流动(元) 11,621,000.0013,312,000.0015,242,000.0023,328,000.00
 存货(元) 139,874,000.00182,735,000.00180,719,000.00266,864,000.00
 可收回本期税项(元) 10,703,000.0075,195,000.0072,371,000.00-
 短期投资(元) 9,953,042,000.009,425,778,000.007,034,569,000.004,988,240,000.00
 流动资产合计(元) 11,830,556,000.0011,769,025,000.0012,126,396,000.0013,115,087,000.00
非流动资产:
 物业、厂房及设备(元) 979,617,000.001,058,962,000.00993,781,000.00949,422,000.00
 无形资产(元) 8,520,000.008,753,000.009,699,000.001,315,000.00
 预付款项及其他长期应收款非流动(元) 72,336,000.0081,833,000.00190,750,000.00174,677,000.00
 递延所得税资产非流动(元) 29,790,000.0098,688,000.0071,118,000.0064,821,000.00
 长期投资(元) 684,285,000.00657,767,000.00661,440,000.00697,115,000.00
 非流动资产其他项目(元) 52,870,000.0049,982,000.0061,384,000.0063,347,000.00
 非流动资产合计(元) 1,827,418,000.001,955,985,000.001,988,172,000.001,950,697,000.00
总资产(元) 13,657,974,000.0013,725,010,000.0014,114,568,000.0015,065,784,000.00
流动负债:
 短期债务及长期负债本期部分(元) 76,089,000.00205,277,000.004,651,000.001,605,000.00
 融资租赁负债流动(元) 5,806,000.005,990,000.005,993,000.006,367,000.00
 应付账款及票据(元) 973,949,000.00819,530,000.00905,923,000.00334,294,000.00
 应付税项流动(元) 41,258,000.00--158,540,000.00
 其他应付款及应计费用(元) 29,089,000.00139,547,000.00141,993,000.0020,083,000.00
 递延收入流动(元) 21,713,000.0019,285,000.0033,075,000.0043,972,000.00
 流动负债合计(元) 1,147,904,000.001,189,629,000.001,091,635,000.00564,861,000.00
非流动负债:
 长期债务(元) 177,817,000.0010,989,000.0011,513,000.0016,629,000.00
 融资租赁负债非流动(元) 39,271,000.0040,929,000.0052,516,000.0057,118,000.00
 递延收入非流动(元) 6,065,000.006,548,000.004,477,000.007,265,000.00
 递延所得税负债非流动(元) 263,711,000.00239,029,000.00241,526,000.00325,917,000.00
 非流动负债其他项目(元) 439,000.00630,000.00240,000.00137,000.00
 非流动负债合计(元) 487,303,000.00298,125,000.00310,272,000.00407,066,000.00
总负债(元) 1,635,207,000.001,487,754,000.001,401,907,000.00971,927,000.00
股东权益:
 普通股(元) 100,000.00100,000.00100,000.00100,000.00
 优先股(元) 15,000.0015,000.0015,000.0015,000.00
 股本溢价(元) 541,258,000.00541,258,000.00540,582,000.00547,691,000.00
 留存收益(元) 7,118,516,000.007,239,947,000.007,225,987,000.007,623,373,000.00
 其他储备(元) 1,539,584,000.001,538,013,000.001,538,013,000.001,514,297,000.00
 累计其他全面收益(元) -490,055,000.00-654,462,000.00-383,276,000.00-217,469,000.00
 归属于母公司股东权益(元) 8,709,418,000.008,664,871,000.008,921,421,000.009,468,007,000.00
 少数股东权益(元) 3,313,349,000.003,572,385,000.003,791,240,000.004,625,850,000.00
 股东权益合计(元) 12,022,767,000.0012,237,256,000.0012,712,661,000.0014,093,857,000.00
负债及股东权益合计(元) 13,657,974,000.0013,725,010,000.0014,114,568,000.0015,065,784,000.00
公告日期 2024-04-292023-08-152023-05-012022-12-29
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院